Navigation Links
Chiltern Appoints Jane Turner as Late Phase Director for Europe
Date:2/27/2009

LONDON, Feb. 27 /PRNewswire/ -- Chiltern a leading global clinical research organization announced today that it has appointed Ms. Jane Turner to the post of Director, Late Phase, Europe.

Ms. Turner brings over 24 years of experience to her new position in Chiltern's global Late Phase Organization. Ms. Turner previously held executive positions in both CRO and Pharmaceutical companies, enabling her to acquire considerable knowledge of the operational side of management in both industries. In her most recent position, Jane worked on the management of Late Phase studies with focus on a European setting. Jane's operational base will be Chiltern's global headquarters in Slough, United Kingdom. Jane received a B.Pharm from the University of Nottingham and a Diploma in Clinical Science from the University of Wales.

"I am pleased that Jane chose to bring her expertise and experience to Chiltern," said Steve Albrecht, Chiltern's Senior Director, Late Phase (global). "Our global Late Phase Team has grown significantly over the past few years and Jane's extensive business and operational experience will help us bring innovative and high quality solutions to exceed our sponsors varied Late Phase needs," Steve added.

"I am delighted to join Steve and the global Late Phase group at Chiltern," Jane Turner stated. "There is an increasing demand from both the regulatory authorities and the public for Late Phase studies especially in the domain of drug safety. These requests can negatively affect our sponsors with added costs and time delays; therefore it is imperative that CROs continue to look for innovative solutions while preserving the integrity of the data and the safety of the subjects."

"Jane adds significant strength to our global Late Phase Team," commented James Esinhart, Executive Vice President, Biometrics & Late Phase. "We are experiencing increased demand for Chiltern's Late Phase services utilizing our expertise, our global Call Centers and our web-based data collection platforms to provide sponsors with the unique services required for their marketed products. We are looking forward to Jane's keen insights as we customize our services to meet the needs of the key stakeholders, ie, our sponsors, the regulatory authorities, and the patients."

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience conducting and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern has 1,400 employees located in 24 offices throughout Europe, the Americas and Asia. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions.

    For More Information Contact:
    Catherine Lemercier                       Richard Baptista
    Chiltern International, Inc.              Chiltern International Ltd.
    2111 Palomar Airport Road                 171 Bath Road
    Suite 200                                 Slough
    Carlsbad                                  Berkshire
    CA 92011                                  SL1 4AA
    USA                                       UNITED KINGDOM
    Tel: 1 (760) 707 5025                     Tel: +44 (0) 1753 512 000
    Fax: 1 (760) 707 5022                     Fax: +44 (0) 1753 511 116
    Email:                                    Email:
    Catherine.Lemercier@chiltern.com          Richard.Baptista@chiltern.com


'/>"/>
SOURCE Chiltern
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chilterns Resourcing Solutions Division Appoints New Managers to Spain and the United Kingdom
2. Chiltern and EPS INTERNATIONAL Enter Into a Global Partnership
3. Chiltern Enhances Its Portfolio of Electronic Data Capture (EDC) Services With the Addition of Hosting and eCRF Design Services for DataLabs (by ClinPhone) and Medidata Rave(R) Certification
4. Chiltern Expands Its Global Reach to Latin America
5. Chiltern Announces New Expansion in Portugal
6. Chiltern Opens a New Office in Russia
7. Chiltern Will Sponsor and Present at the 17th Annual Partnerships With CROs Meeting in Las Vegas, April 14 - 16, 2008.
8. Chiltern Wins Top Prize
9. Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
10. Diana Hatsis of Chiltern Will Present at the Joint Commission on Allied Health Personnel in Ophthalmology (JCAHPO) 35th Annual Continuing Education Program Held in Conjunction With the American Academy of Ophthalmology (AAO) Annual Meeting
11. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... ... February 23, 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, ... June: From Not to Hot,” which will begin airing on February 24, 2017. The ... millions from the 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Dr. David ... in Henderson, NV 89052. Dr. Mahon was named a 2017 Top Patient Rated ... is an online directory that recognizes local physicians and dentists who have earned ...
(Date:2/23/2017)... ... 23, 2017 , ... The Center for Autism and Related ... Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. The ... see films in an environment that accommodates their unique needs. , Launched in ...
(Date:2/23/2017)... ... February 23, 2017 , ... HealthPostures, the desk for standing designer headquartered in ... representative to the Minneapolis Home and Garden Show which is being held February 24 ... national attention is the Minneapolis Convention Center. , From its broad line of ...
(Date:2/22/2017)... Raton, FL (PRWEB) , ... February 22, 2017 , ... ... primarily from deer antler velvet, announced its products are coming soon to Amazon.com, the ... Clint and Shelley Thomson as a means to develop an effective natural treatment for ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Feb. 23, 2017  Spheryx, Inc. ... poster presentation at PittCon 2017 Conference and ... is the world,s largest annual premier conference ... a wide array of industry, academic and ... and QA, food safety, environmental, bioterrorism and ...
(Date:2/23/2017)... Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) ( www.provectusbio.com ... dermatology biopharmaceutical company, today announced that it has appointed ... as special advisers to the Company,s Board of Directors.  ... on financial and corporate strategy. Provectus also ... up to $2.5 million from Eric Wachter , ...
(Date:2/23/2017)... DEERFIELD, Ill. , Feb. 23, 2017 /PRNewswire/ ... a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) ... Cognition Holdings PLC and Ctrl Group Limited, announced a ... app on an Apple Watch wearable to monitor and ... (MDD). Depression (MDD) is the leading cause ...
Breaking Medicine Technology: